BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Other Non-current Liabilities
Long-term obligations not reported separately, such as lease or pension liabilities.
BillionToOne, Inc.NASDAQ: BLLN
Other Non-current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Other non-current liabilities remains negative
Q2 FY2026 other non-current liabilities was $0, compared with $2.72M a year earlier.
Context
- Other non-current liabilities amounted to 0.0% of total assets at the end of Q2 FY2026, down 0.9 pp from a year earlier.
- Other non-current liabilities increased in 1 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether other non-current liabilities keeps falling in the next quarterly balance sheet after a -100.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Other Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 2.76M | +53.6% |
| FY2023 | 2023-12-31 | 1.8M | — |
Other Non-current Liabilities vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 other non-current liabilities of $0 is the 8th highest of the 9 companies compared; the peer median is $1.79M.
- Its year-over-year change of -100.0% is the 7th highest of 8, against a peer median of -62.0%.
- Other non-current liabilities amounts to 0.0% of total assets for BLLN, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $122.95M | — | — | 4.6% | |
| Sep 2026 | $118.75M | +25.8% | +140.6% | 6.3% | |
| Jun 2026 | $3.17M | +21.1% | — | 0.1% | |
| Mar 2026 | $1.89M | -62.0% | -16.8% | 0.2% | |
| Mar 2026 | $1.7M | -50.0% | -64.2% | 0.3% | |
| Jun 2026 | $259K | -76.0% | -57.8% | 0.0% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $71K | -97.8% | — | 0.0% |
BLLNBillionToOne, Inc. | Jun 2026 | $0 | -100.0% | — | 0.0% |
| Jun 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding BLLN) | $1.79M | -62.0% | -37.3% | 0.1% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.